At 6.2% CAGR, Europe Cough Drops Market is Projected to be Worth US$ 1,085.56 Million by 2031, says Business Market Insights

According to Business Market Insights research, the Europe cough drops market was valued at US$ 669.47 million in 2023 and is expected to reach US$ 1,085.56 million by 2031, registering a CAGR of 6.2% from 2023 to 2031. Focus on natural ingredients and sustainable packaging and increasing shift toward self-medication are among the critical factors attributed to driving the Europe cough drops market growth.

Homemade herbal remedies have been in use for centuries to alleviate coughs and sore throats. With a renewed interest in natural healing practices, many consumers are turning to herbal cough drops, including herbal blends such as thyme or licorice root, as effective alternatives to conventional allopathic options. Consumer awareness about health and wellness is driving the demand for cough drops that contain natural and organic ingredients. People are becoming increasingly aware of the potential side effects of synthetic ingredients incorporated in medications. Thus, there is a growing preference for natural remedies that contain herbal extracts, organic flavors, and other natural constituents. Products containing ingredients such as honey, ginger, and eucalyptus are becoming increasingly popular due to their throat-soothing properties. In response to the growing consumer inclination toward natural alternatives, manufacturers have begun investing significant resources in innovation for the development of cough drops with herbal extracts and organic flavors. In September 2023, Ricola announced a launch of cough drops that combine Swiss herbs, appealing to traditional herbal remedy enthusiasts. The global shift toward natural ingredients is not confined to developed markets; emerging economies are also witnessing a significant increase in demand for herbal and natural products. Manufacturers could take advantage of this trend by expanding their distribution networks into areas where natural remedies are culturally favored. Moreover, as consumers become more environmentally conscious, manufacturers that implement sustainable practices in sourcing and packaging can stand out in the market. Utilizing eco-friendly materials and promoting the sustainable sourcing of natural ingredients can strengthen brand loyalty among environmentally aware consumers. In April 2021, HALLS announced a partnership with TerraCycle to make all cough and sore throat drop packaging recyclable in the US. Collectors earn points for each shipment of packaging waste sent to TerraCycle, which is donated to a nonprofit, school, or charity of their choice. Thus, the surging focus on natural ingredients and sustainable packaging is projected to create significant growth opportunities for the cough drops in the near future.

On the contrary, the inability to provide long-term relief and availability of alternatives hampers the growth of Europe cough drops market.

By product, the Europe cough drops market is segmented into gluten free, sugar free and others. The sugar free held 46.7% share of Europe cough drops market share in 2023, amassing US$ 312.77 million. It is projected to garner US$ 519.51 million by 2031 to register 6.5% CAGR during 2023–2031.

By application, the Europe cough drops market is bifurcated into adults and children. The adults held 83.8% share of Europe cough drops market share in 2023, amassing US$ 561.19 million. It is projected to garner US$ 920.83 million by 2031 to register 6.4% CAGR during 2023–2031.

By distribution channel the Europe cough drops market is bifurcated into offline and online. The offline held 68.8% share of Europe cough drops market share in 2023, amassing US$ 460.38 million. It is projected to garner US$ 740.55 million by 2031 to register 6.1% CAGR during 2023–2031.

Based on country, the Europe cough drops market is categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that the UK captured 24.6% share of Europe cough drops market in 2023. It was assessed at US$ 164.82 million in 2023 and is likely to hit US$ 270.91 million by 2031, registering a CAGR of 6.4% during 2023–2031.

Key players operating in the cough drops market are Bliss GVS Pharma Ltd, Cipla Ltd, Gepach International, GSK Plc, Mondelez International Inc, Reckitt Benckiser Group Plc, Ricola, Sanofi SA, The Procter & Gamble Co, and Thornton & Ross, among others.

• In September 2024: Cofsils, a brand by Cipla Health Ltd. specializing in sore throat relief, launched a new flavor: Cofsils Mulethi. This lozenge offers the soothing taste of Mulethi (Licorice) and provides relief from sore throat in just five minutes. Cofsils Mulethi joined the existing flavors, including Cofsils Fresh Mint, Cofsils Tulsi Pudina, and popular options like Cofsils Orange, Lemon Honey, and Ginger Lemon.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com